4129.TWO · UOC
Taiwan · RS rating 27 · As of 2026-10-08
| Price | 83.70 TWD |
|---|---|
| 1-day change | +0.1% |
| RS rating (overall / 1M / 3M / 12M) | 27 / 59 / 45 / 21 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 36 / 22 / 47 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | +56.2% |
| Sales growth Q/Q | +4.7% |
| Distance from 52-week high | +36.1% |
| Market cap (USD) | $248.6M |